Ultragenyx Pharmaceutical reported $-245106000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Aptinyx Inc APTX:US USD -15303000 2.36M
Biocryst Pharmaceuticals BCRX:US USD -42520000 16.34M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Bluebird Bio BLUE:US USD -76520000 23.62M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Insmed INSM:US USD -131145000 35.5M
IONIS PHARMACEUT IONS:US USD -46992000 58.14M
Karyopharm Therapeutics KPTI:US USD -36324000 12.74M
Kyowa Hakko Kirin 4151:JP JPY 14.2B 4.78B
Macrogenics MGNX:US USD -24813000 16.49M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Moderna Inc MRNA:US USD 1.04B 1.15B
Neurocrine Biosciences NBIX:US USD 68.5M 85.4M
Ptc Therapeutics PTCT:US USD -109315000 42.77M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M
Vital Therapies VTL:US USD -21224000 677K
Xoma XOMA:US USD -4178000 492K